Wednesday, January 23, 2013

Baylor College of Medicine to lead NIH study on H3N2v influenza vaccine

HOUSTON – (Jan. 22, 2013) – Baylor College of Medicine is the lead site on a study launched by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, that will measure the safety and the antibody responses among healthy adults immunized with an H3N2v vaccine, also known as H3N2 variant.

Online Subscription required:

No comments: